Study shows GHRH antagonist's role in AML drug resistance

A new research paper was published in Oncotarget's Volume 15 on April 8, 2024, entitled, "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia."

Related Keywords

Miami ,Florida ,United States ,University Of Miami ,Florida Atlantic University ,Rama Abdin ,Joaquinj Jimenez ,Simonettai Gaumond ,Joel Costoya ,Andrewv Schally ,Veterans Affairs Medical Center ,Acute Myeloid Leukemia ,Doxorubicin ,Leukemia ,Myeloid Leukemia ,One ,Bone Marrow ,Dancer ,Fell ,Chemotherapy ,Growth Hormone ,Ormone ,Ncology ,Proliferation ,Research ,